As Wnt signaling is deregulated in NPC, we hypothesized that pharmacological intervention of Wnt signaling with the CBP/β-catenin antagonist ICG-001 could be used to reduce the CSC-like population. This evidence concerns the gene CREBBP and nasopharyngeal carcinoma.